Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR-3: Hormone Stabilization for Proximal Suicide Risk
NCT04112368Phase 4Completed
- Sponsor
- University of Illinois Chicago
- Start
- Sep 2020
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of estradiol topical, progesterone in suicidal ideation, sponsored by University of Illinois Chicago. Started Sep 2020; status: completed.
02
Drugs
estradiol topicalprogesterone
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT04112368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04112368.